▟ Vinebot intrinsic value, daily

← back

CLX Clorox

consumer_staples · valued with opus medium conviction · deep-dived 2026-10-29

HOLD
Intrinsic value$49.35
Price (at call)$86.84
Margin of safety -43.2%
vs market (rating basis) -7.2%

Wounded staples franchise; value hinges on margins returning to ~16.5%, not on growth.

The story

Clorox is a mature household-staples franchise (bleach, Glad, Kingsford, Hidden Valley, Brita) with strong shelf positions in the US, but the last five years have been rough. The COVID demand spike faded, cost inflation squeezed margins, a 2023 cyberattack disrupted operations, the ERP cutover caused problems, and the company sold off Argentina and VMS. Revenue is shrinking while it pushes margins back toward its historical mid-to-high teens. It is a no-growth, cash-generating business with meaningful leverage and steady pressure from private labels.

After the divestitures and ERP disruption, revenue should stabilize with low-single-digit growth that converges to inflation-like 2%. Pricing and cost savings rebuild margins to about 16.5%, below the pre-COVID 18% peak because retailer and private-label pressure persists. Reinvestment needs are low since this is a mature brand portfolio. Beta stays at the staples anchor, with a small failure probability reflecting about 3.5x net debt to EBITDA.

Value drivers

Revenue growth (Y1)1.0%
Terminal growth2.0%
Forecast horizon6y
Target operating margin16.5%
Years to target margin4
Sales-to-capital1.50
Beta0.70
Failure probability2.0%
Cost of capital (WACC)7.8%
Terminal WACC8.7%

Valuation bridge

PV of explicit FCFF3.58B
PV of terminal value7.59B
Equity value5.97B
÷ shares → per share$49.35

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 6.79B 1.0% 14.4% 742.80M 44.80M 698.00M 647.44M
2 6.87B 1.2% 15.1% 788.18M 54.30M 733.88M 631.42M
3 6.96B 1.4% 15.8% 836.18M 64.11M 772.07M 616.17M
4 7.08B 1.6% 16.5% 887.12M 74.29M 812.83M 601.71M
5 7.20B 1.8% 16.5% 903.09M 84.91M 818.18M 561.80M
6 7.35B 2.0% 16.5% 921.15M 96.05M 825.11M 525.52M

Key risks

  • Private-label share gains and promotional intensity cap pricing power and margin recovery
  • Volume declines persist beyond ERP and divestiture effects, signaling structural brand erosion
  • Leverage (net debt ~4.9B) limits flexibility; dividend commitments could strain cash flow if margins stall

Catalysts

  • Lapping of ERP transition and divestiture comps showing organic volume stabilization
  • Gross margin rebuild from cost savings program and commodity relief lifting EBIT margin back above 15%

History

DatePriceIntrinsicMoSRating
2026-10-29$86.84 $49.35 -43.2% HOLD
2026-09-21$83.10 $37.15 -55.3% HOLD
2026-08-12$108.25 $51.30 -52.6% HOLD
2026-07-02$96.42 $97.45 +1.1% STRONG BUY
2026-06-23$92.64 $100.27 +8.2% STRONG BUY